We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Content Image Acquisition and Analysis Software Designed for Biologic Research

By LabMedica International staff writers
Posted on 13 Aug 2012
High content image acquisition and analysis software has been designed to slash analysis time from hours to minutes.

Molecular Devices, LLC (Sunnyvale, CA, USA), announced the launch of MetaXpress 5.0 high content image acquisition and analysis software, which has been designed to improve the ease and speed of custom analysis using the company’s ImageXpress Micro and Ultra systems.

The new software enables user-created analysis to be run on MetaXpress PowerCoreSoftware, which harnesses the speed of parallel processing and instantly cuts analysis time from hours to minutes. More...
An interactive tool incorporated into the software allows users to create custom analysis easily, without resorting to dedicated programming expertise. The system includes a total of 19 predesigned analysis routines, with the facility to freely add in custom steps to create a customized analysis. MetaXpress 5.0 also features object click-to-find, allowing scientists to rapidly identify objects of interest within their images. Investigators can easily import data from third party hardware, and export measurements to a variety of formats with the new MDCStore Xchange Service plug-in.

Zheng Yang, a computational biologist in the biotech industry, commented, “This unique software solution addresses the specificity required for common image analysis problems, yet offers the flexibility sought after in advanced development for high content screening methods. The MetaXpress Software has dramatically increased the speed and throughput of high content and morphometric screening of our neuron cultures. The ability to apply a custom analysis module to all images captured from a single well in batch form saves significant time in our screening workflow.”

“With the release of MetaXpress 5.0, our software can now analyze images using custom analysis routines at speeds that will keep up with acquisition,” said Grischa Chandy, product manager of Cellular Imaging at Molecular Devices, LLC. “ImageXpress Systems combined with MetaXpress Software offer some of the fastest high content screening solutions available, significantly improving screening workflow, and providing the flexibility needed for the research environment.”

Related Links:

Molecular Devices



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.